Carregant...
Safety and Efficacy of Rivastigmine in Adolescents with Down Syndrome: A Preliminary 20-Week, Open-Label Study
Individuals with Down syndrome (DS) exhibit a cholinergic deficiency similar to that found in Alzheimer’s disease. Cholinesterase inhibitors, used to treat Alzheimer’s disease, may improve cognitive function in individuals with DS. This is the first investigation of the safety and efficacy of rivast...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2006
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3129997/ https://ncbi.nlm.nih.gov/pubmed/17201619 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/cap.2006.16.755 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|